ArticleJournal of neurosurgery2018

A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab.

Rika Fujii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.